Cheng, Senping,Li, Xiaoling,Deng, Feihuang,Yao, Juan
申请号：
AU2018212273
公开号：
AU2018212273A1
申请日:
2018.01.25
申请国别(地区):
AU
年份:
2019
代理人:
摘要：
A dosage form of controlled release at specific gastrointestinal sites is provided. The dosage form includes a shell defining a first and a second compartment, a first active phamaecutical ingredient (API) loaded in the first compartment, and a second API loaded in the second compartment, wherein the first API and the second API can be the same or different. The shell includes a first material soluble in a first gastrointestinal site and a second material soluble in a second gastrointestinal site.
